Loading
Latest filing published 26 Mar 2026 for SK바이오사이언스, €116k. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
김훈 is a declared insider of SK바이오사이언스, with filings sourced from DART (FSS). We count 54 filings; the first trade dates from 25 March 2021 and the latest from 24 March 2026.
On the market, this insider has only ever bought: 54 purchases, €116k in total. The totals do not cover 53 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 1 purchase and no sales.
Across 53 purchases, this insider has always bought alone, with no colleague buying within 30 days.
Most recently, on 26 March 2026, the filings show an open-market purchase worth €116k in SK바이오사이언스. The median gap between a trade and its publication by DART (FSS) is 2 days. That lag is the time during which only the insider knows about the trade. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 54 declarations